Why Sonnet BioTherapeutics Stock Is Trading Higher Today
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) is trading significantly higher Tuesday after the company announced the successful completion of the discovery phase for its next preclinical pipeline candidate, SON-1410.
